| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PCRX | Exit | PACIRA BIOSCIENCES INC | $0 | – | -5,000 | -100.0% | -0.50% | – |
| BFS | Exit | SAUL CTRS INC | $0 | – | -5,000 | -100.0% | -0.58% | – |
| Exit | ECOVYST INC | $0 | – | -100,000 | -100.0% | -3.22% | – | |
| DMAC | Exit | DIAMEDICA THERAPEUTICS INC | $0 | – | -470,000 | -100.0% | -3.97% | – |
| UBS | Exit | UBS GROUP AG | $0 | – | -75,000 | -100.0% | -6.06% | – |
| AR | Exit | ANTERO RESOURCES CORP | $0 | – | -75,000 | -100.0% | -6.24% | – |
| IRIX | Exit | IRIDEX CORP | $0 | – | -1,000,000 | -100.0% | -8.32% | – |
| EPSN | Exit | EPSILON ENERGY LTD | $0 | – | -825,000 | -100.0% | -14.27% | – |
| AEM | Exit | AGNICO EAGLE MINES LTD | $0 | – | -125,000 | -100.0% | -18.62% | – |
| NVGS | Exit | NAVIGATOR HLDGS LTD | $0 | – | -789,548 | -100.0% | -38.21% | – |
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NAVIGATOR HOLDINGS LTD | 40 | Q3 2023 | 38.2% |
| IRIDEX CORP | 40 | Q3 2023 | 23.4% |
| COMMUNITY BANKERS TR CORP | 28 | Q3 2020 | 10.5% |
| PAR PETROLEUM CORP | 26 | Q2 2020 | 15.3% |
| REATA PHARMACEUTICALS INC | 22 | Q3 2021 | 34.4% |
| EPSILON ENERGY LTD | 19 | Q3 2023 | 16.6% |
| CAREDX INC | 16 | Q2 2019 | 6.6% |
| FORESTAR GROUP INC | 16 | Q4 2019 | 3.0% |
| SPDR S&P 500 ETF TR | 13 | Q3 2022 | 34.2% |
| HOWARD HUGHES CORP | 13 | Q1 2019 | 5.5% |
View PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Epsilon Energy Ltd. | June 12, 2023 | 900,000 | 3.9% |
| IRIDEX CORP | November 23, 2022 | 963,250 | 6.0% |
| CareDx, Inc. | January 24, 2018 | 1,133,000 | 3.9% |
| CASCADE MICROTECH INC | November 04, 2014 | 950,000 | 5.8% |
| SPECTRANETICS CORP | October 02, 2012 | 1,700,000 | 4.9% |
| DUSA PHARMACEUTICALS INC | May 26, 2011 | 1,218,500 | 5.0% |
| SENORX INC | May 07, 2010 | 140,993 | 0.8% |
| TRANSCOMMUNITY FINANCIAL CORP | March 21, 2008 | 445,000 | 9.7% |
| ARONEX PHARMACEUTICALS INC | January 25, 2000 | 1,138,111 | 5.0% |
| APPLIED IMAGING CORP | January 20, 2000 | 483,833 | 4.0% |
View PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| SC 13D/A | 2023-06-12 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-13 |
| SC 13D | 2022-11-23 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-16 |
View PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.